Clinical Trial Update: Adjuvant Trial in Patients With Resected PDAC Randomized to Allocation of Oxaliplatin- or Gemcitabine-based Chemotherapy by Standard Clinical Criteria or by a Transcriptomic Treatment Specific Stratification Signature [Phase 3]

View source ↗

Summary

Phase 3 adjuvant trial comparing oxaliplatin- versus gemcitabine-based chemotherapy for resected pancreatic ductal adenocarcinoma, with treatment allocation pot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pancreatic Ductal Adenocarcinoma

Drugs mentioned

• Gemcitabine-based chemotherapy (gemcitabine)
• Oxaliplatin-based chemotherapy (oxaliplatin)

Snippet

Sponsor: John Neoptolemos | Conditions: Pancreatic Ductal Adenocarcinoma | Phase 3 | Status: NOT_YET_RECRUITING